Memorializing Governor Kathy Hochul to proclaim March 2026 as Kidney Month in the State of New York
Summary
This resolution memorializes Governor Kathy Hochul to proclaim March 2026 as Kidney Month in New York State. It is a public-awareness measure focused on chronic kidney disease (CKD), describing CKD as an under-recognized health crisis that affects more than one in seven adults nationally and more than 2.2 million adults in New York. The resolution emphasizes that many people with CKD do not know they have it because symptoms often do not appear until later stages, and it highlights the importance of screening, early detection, and disease management.
The resolution also points to the broader burden of kidney disease in New York, including rising CKD prevalence, low testing rates among people with risk factors, and the number of residents with end-stage renal disease waiting for kidney transplants. It notes that March is already National Kidney Month and that March 12 is World Kidney Day, using those observances as support for a state proclamation. The measure does not create a regulatory program, funding stream, or enforcement mechanism; instead, it is a ceremonial request that the Governor issue a proclamation and that the resolution be transmitted to her office.
Impact
Because this is a Senate resolution, it does not amend the Public Health Law or any other statute, and it does not impose duties on state agencies, providers, insurers, or patients. Its practical effect is limited to encouraging executive recognition of Kidney Month and raising public awareness about CKD, kidney failure, screening, and transplant needs. Any legal impact is indirect, through potential attention to kidney health education and prevention efforts rather than through binding changes to state law.
Sentiment
The overall sentiment around the bill is strongly supportive and commemorative. The resolution frames kidney disease as a serious but often hidden public health problem and presents the proclamation as a way to promote awareness, early testing, and prevention. No votes or committee transcripts are provided, but the text itself is affirmative and advocacy-oriented, suggesting broad consensus rather than controversy.
Contention
There is little apparent contention in the bill as drafted because it is a nonbinding memorializing resolution rather than substantive legislation. The only possible point of discussion is whether a proclamation meaningfully advances kidney health outcomes or whether state attention should instead focus on screening access, treatment, and transplant availability. However, no opposing arguments, amendments, or recorded objections are included in the available materials.